| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.090 | Biomarker | disease | BEFREE | Long intergenic non-coding RNA for kinase activation (LINK-A) long non-coding RNA (lncRNA) has been characterized in triple negative breast cancer, but its potential involvement in glioma has not been investigated. | 31410112 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | BACKGROUND LINK-A lncRNA acts as an oncogene in triple-negative breast cancer, but its involvement in other diseases is unknown. | 30636001 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | Long intergenic non-coding RNA for kinase activation (LINK-A) has been characterized as an oncogenic long non-coding RNA (lncRNA) in triple-negative breast cancer. | 31404323 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | BACKGROUND The functionality of LINK-A lncRNA as an oncogenic lncRNA has only been characterized in triple-negative breast cancer. | 30912527 | 2019 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | Patients with programmed ccll death protein-1(PD-1) blockade-resistant TNBC exhibited elevated LINK-A levels and downregulated PLC components. | 31160797 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | Long intergenic non-coding RNA for kinase activation (LINK-A) long non-coding RNA (lncRNA) is an oncogenic lncRNA in triple-negative breast cancer. | 31186711 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | <b>Introduction</b>: LINK-A lncRNA is a well-characterized oncogenic lncRNA only in triple negative breast cancer. | 30061183 | 2018 | ||||
|
0.090 | Biomarker | disease | BEFREE | Long intergenic non-coding RNA for kinase activation (LINK-A), belonging to one of the intergenic lncRNAs, was reported to regulate signaling pathways correlated with triple-negative breast cancer. | 28714007 | 2017 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | Both LINK-A expression and LINK-A-dependent signalling pathway activation correlate with triple-negative breast cancer (TNBC), promoting breast cancer glycolysis reprogramming and tumorigenesis. | 26751287 | 2016 |